About Artificial Intelligence companies in Clinical Trials Tech
There are 61 Artificial Intelligence companies in Clinical Trials Tech, including 28 funded companies having collectively raised $2.24B in venture capital money and private equity. Out of these, 12 are Series A+ funded, and 3 have achieved unicorn status.
Artificial Intelligence companies in Clinical Trials Tech has seen 3 acquisitions and 1 IPO. This represents almost 6.6% of all such companies - which is higher than the 3.8% exit rate of tech companies in general.
Clinical Trials Tech sector is also known as Clinical TrialsTech, Clinical Trials-Tech, Digital Clinical Trials or Clinical Trials Technology Solutions.
Top Artificial Intelligence companies in Clinical Trials Tech
There are more than 61 Artificial Intelligence companies in Clinical Trials Tech. Tempus is the top Artificial Intelligence company in Clinical Trials Tech, ranked using Tracxn Score (what's this?).
Here are 5 of the top Artificial Intelligence companies in Clinical Trials Tech:
Company | Description | Location | Founded | Current Stage | Private Funding Raised |
|---|---|---|---|---|---|
Developer of genomic testing and artificial intelligence tools for medicine | Chicago (United States) | 2015 | Public | $1.05B | |
Developer of an AI platform for clinical trial design and analysis | San Francisco (United States) | 2017 | Series C | $135M | |
Developer of an AI-powered platform for care coordination and disease detection | San Francisco (United States) | 2016 | Series D | $252M | |
Provider of AI-based clinical trail management tool for researchers | Tel Aviv (Israel) | 2020 | Series B | $64.6M | |
Provider of AI-powered clinical trial simulation | Warsaw (Poland) | 2023 | Seed | $25M |
Artificial Intelligence companies founded year-on-year in Clinical Trials Tech
3 new startups have been founded so far in 2026 in Artificial Intelligence companies in Clinical Trials Tech. 11 Artificial Intelligence startups in Clinical Trials Tech were founded in 2025 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | 3 |
2025 | 11 |
2024 | 5 |
2023 | 8 |
2022 | 3 |
2021 | 4 |
2020 | 2 |
2019 | 3 |
2018 | 2 |
2017 | 1 |
Stage-wise distribution of Artificial Intelligence companies in Clinical Trials Tech
Out of the total 61 Artificial Intelligence companies in Clinical Trials Tech, 28 have secured funding. Among them, 12 have reached Series A or higher, and 10 to Series B or beyond.
Founded - 61
Funded - 28
Series A+ - 12
Series B+ - 10
Series C+ - 8
Company Stage | No. of companies |
|---|---|
Founded | 61 |
Funded | 28 |
Series A+ | 12 |
Series B+ | 10 |
Series C+ | 8 |
Let us walk you through our Sectors and other offerings
Designed with precision for VCs, PE, IBs, Incubators, M&A, Innovation more
Designed with precision for VCs, PE, IBs, Incubators, M&A, Innovation more
Funding Trends in Artificial Intelligence companies in Clinical Trials Tech
Total funding year-on-year in Artificial Intelligence companies in Clinical Trials Tech
Artificial Intelligence companies in Clinical Trials Tech saw a total funding of more than $2.2B in the last 10 years. The most amount of funding has been in 2026 at more than $558M till date.
- Total Funding
Year | Total Funding |
|---|---|
2026 | $558M |
2025 | $28.7M |
2024 | $94.5M |
2023 | $85.5M |
2022 | $196M |
2021 | $71.1M |
2020 | $414M |
2019 | $292M |
2018 | $362M |
2017 | $98.4M |
Recent Funding Rounds in Artificial Intelligence companies in Clinical Trials Tech
In the year 2026, till October 2026, Artificial Intelligence companies in Clinical Trials Tech have raised $97.6M in equity funding across 9 rounds.
In the same period last year (i.e. till October 2025), Artificial Intelligence companies in Clinical Trials Tech had raised $26.4M across 7 rounds.
So, 2026 has seen a 269.79% rise in funding in Artificial Intelligence companies in Clinical Trials Tech as compared to 2025.
Here are some recent, important funding rounds in Artificial Intelligence companies in Clinical Trials Tech:
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Seed | 4434 | Oct 27, 2026 | ||
Seed | 8099 | Oct 07, 2026 | ||
Series B | 1546 | Aug 04, 2026 | and 7 more | |
Seed | 7181 | Jul 01, 2026 | ||
Seed | 9453 | Jul 01, 2026 |
Top Investors in Artificial Intelligence companies in Clinical Trials Tech
New Enterprise Associates is the top investor in Artificial Intelligence companies in Clinical Trials Tech based on number of companies invested.
Here are some top investors in Artificial Intelligence companies in Clinical Trials Tech:
Investor | Location | Top Portfolio Companies |
|---|---|---|
Menlo Park (United States) | ||
Baltimore (United States) | ||
Washington, DC (United States) | AiCure and Modality.AI | |
Mountain View (United States) | ||
Washington, DC (United States) |
M&A activity in Artificial Intelligence companies in Clinical Trials Tech
In the year 2025, till March 2025, 1 acquisition happened in Artificial Intelligence companies in Clinical Trials Tech.
Here are some recent, important acquisitions in Artificial Intelligence companies in Clinical Trials Tech:
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Business Acquisition | Mar 11, 2025 | ||
Business Acquisition | Nov 15, 2023 | ||
Business Acquisition | Feb 06, 2023 |
Acquisition trends in Artificial Intelligence companies in Clinical Trials Tech
Here are the acquisition trends in Artificial Intelligence companies in Clinical Trials Tech:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | - |
2025 | 1 |
2024 | - |
2023 | 2 |
2022 | - |
2021 | - |
2020 | - |
2019 | - |
2018 | - |
2017 | - |
IPOs in Artificial Intelligence companies in Clinical Trials Tech
In the year 2024, till June 2024, 1 IPO happened in Artificial Intelligence companies in Clinical Trials Tech.
Here are some recent, important IPOs in Artificial Intelligence companies in Clinical Trials Tech:
Company | IPO Date | Exchange Symbol |
|---|---|---|
Jun 14, 2024 | National Association of Securities Dealers Automated Quotations (NASDAQ) |
Colleges which produce the most Artificial Intelligence companies in Clinical Trials Tech
Companies founded by alumni from top colleges in Artificial Intelligence companies in Clinical Trials Tech
Most number of Artificial Intelligence startups in Clinical Trials Tech have been founded by alumni from Harvard University, University of Cambridge and Duke University.
College | No. of companies |
|---|---|
Harvard University | 3 |
University of Cambridge | 3 |
Duke University | 2 |
Massachusetts Institute of Technology | 2 |
Stanford University | 2 |
Yale University | 2 |
BITS Pilani | 1 |
Carnegie Mellon University | 1 |
ESSEC Business School | 1 |
IIT Roorkee | 1 |
Total funding in Artificial Intelligence companies founded by alumni from top colleges in Clinical Trials Tech
In the last 10 years, graduates from University of Cambridge have raised the most funding for Artificial Intelligence companies in Clinical Trials Tech, compared to alumni from other top colleges. Stanford Business School and Stanford University alumni are second.
College | Total Funding |
|---|---|
University of Cambridge | $372M |
Stanford Business School | $292M |
Stanford University | $292M |
University College London | $292M |
Harvard University | $127M |
Duke University | $77.1M |
University of Pennsylvania | $72.8M |
Wharton School | $72.8M |
University of California (Los Angeles) | $54.8M |
IIT Roorkee | $50.9M |
Top News in Artificial Intelligence companies in Clinical Trials Tech
•
•
•
•
•
•
Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWEBusiness Wire•Apr 09, 2026•Gilead, Tempus
•
Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel DeviceBusiness Wire•Sep 11, 2025•Tempus
•
Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-Low EF SoftwareBusiness Wire•Jul 16, 2025•Tempus
•
•
HEALWELL Announces Update: AI Performance, Pentavere Acquisition, and Enhanced IntegrationFinanzNachrichten•Jul 16, 2025•HEALWELL AI, Pentavere
